DrSerge Zolotukhin
PROF
MD-PEDIATRICS
GRANTS
- GRANTA Novel Gene Therapy to Target Glioblastoma via Custom-Engineered Adenovirus-Associated Viral VectorsCalifornia Institute for Regenerative Med11 Apr 2025 - 31 Oct 2027
- GRANTEngineering AAV for safe and efficient gene delivery to the human retinaNational Institute of Health Nei5 Sep 2024 - 30 Jun 2029
- GRANTTask Order 14 - Directed Evolution of AAV Combinatorial Capsid Libraries to Derive Human Targeted CapsidsSolid Biosciences Inc4 Aug 2021 - 31 May 2025
- GRANTArtificial intelligence-directed approach in human tissue manufacturing for therapeutic targetingSarepta Therapeutics6 Jul 2020 - 31 Dec 2023
- GRANTAavanti Task Order #2 - Molecular biology support for development of rAAV vectors for SARS-CoV2 Vaccine*aavantibio16 Apr 2020 - 23 Sep 2020
- GRANTSTTR - Phase 2 - Targeting glioblastoma stem-like cells with custom-designed viral vectorsNational Institute of Health Nci20 Dec 2019 - 31 Aug 2022
- GRANTEngineering AAV for safe and efficient gene delivery to the human retinaNational Institute of Health Nei29 Aug 2019 - 31 May 2024
- GRANTDevelopment of a Novel AAV Vector Capsid Optimized for OA Gene TherapyUS Army Med Research Acquisition15 Aug 2019 - 14 Aug 2026
- GRANTSTTR - Targeting glioblastoma stem-like cells with custom-designed viral vectorsNational Institute of Health Nci26 Jun 2018 - 30 Jun 2019
- GRANTUse of barcoded genomes to determine the frequency of transduction and gene expression of approximately 34 serotypes/mutants of rAAV in various regions of the primate brain*lacerta Therapeutics1 Feb 2018 - 31 Dec 2019
- GRANTOptimizing AAV Vectors for Central Nervous System transductionNational Institute of Health Ninds27 Jul 2017 - 30 Nov 2023
- GRANTAAV Capsid Library ScreeningApplied Genetics Tech Corporation2 Sep 2014 - 31 Aug 2018